NCT00354185 2013-05-16PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Terminated36 enrolled